Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer

[1]  R. Miceli,et al.  Extracellular matrix proteins as diagnostic markers of breast carcinoma , 2018, Journal of cellular physiology.

[2]  D. Carbone,et al.  Blood-based biomarkers in lung cancer: prognosis and treatment decisions. , 2017, Translational lung cancer research.

[3]  Ash A. Alizadeh,et al.  Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling. , 2017, Cancer discovery.

[4]  J. Hung,et al.  Secreted protein acidic and rich in cysteine (SPARC) induces cell migration and epithelial mesenchymal transition through WNK1/snail in non-small cell lung cancer , 2017, Oncotarget.

[5]  M. Cheng,et al.  Clinicopathological and prognostic significance of circulating tumor cells in patients with lung cancer: a meta-analysis , 2017, Oncotarget.

[6]  P. Pandolfi,et al.  Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling. , 2017, Cancer research.

[7]  F. Ma,et al.  Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysis , 2017, Molecular and clinical oncology.

[8]  G. Botti,et al.  Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer. , 2017, Translational lung cancer research.

[9]  D. Xie,et al.  Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non–Small Cell Lung Cancer Using Next-Generation Sequencing , 2017, Clinical Cancer Research.

[10]  M. Sukkar,et al.  The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease , 2017, British journal of pharmacology.

[11]  Tuan Zea Tan,et al.  A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets. , 2016, Cancer letters.

[12]  J. Karlsson,et al.  The extracellular matrix – the under‐recognized element in lung disease? , 2016, The Journal of pathology.

[13]  M. Colombo,et al.  Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity. , 2016, Cell reports.

[14]  Hua-Chuan Zheng,et al.  SPARC expression in gastric cancer predicts poor prognosis: Results from a clinical cohort, pooled analysis and GSEA assay , 2016, Oncotarget.

[15]  Changhong Miao,et al.  COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance. , 2016, Oncology reports.

[16]  B. Nemesure,et al.  Five-Year Survival Among Stage IIIA Lung Cancer Patients Receiving Two Different Treatment Modalities , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[17]  M. Callari,et al.  Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types. , 2015, Seminars in cancer biology.

[18]  Giuseppe Merlino,et al.  Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression. , 2015, Seminars in cancer biology.

[19]  U. Pastorino,et al.  Conversion to stem‐cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells , 2015, Molecular oncology.

[20]  I. Rizos,et al.  Development of novel real-time PCR methodology for quantification of COL11A1 mRNA variants and evaluation in breast cancer tissue specimens , 2015, BMC Cancer.

[21]  P. Carmeliet,et al.  The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated Fibroblasts. , 2015, Cell reports.

[22]  V. Prod’homme,et al.  Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis , 2015, Nature Communications.

[23]  E. White.  Lung extracellular matrix and fibroblast function. , 2015, Annals of the American Thoracic Society.

[24]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[25]  Daniel S. Puperi,et al.  Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma. , 2015, The Journal of clinical investigation.

[26]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[27]  Wei Wang,et al.  Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer , 2014, Scientific Reports.

[28]  V. Weaver,et al.  The extracellular matrix modulates the hallmarks of cancer , 2014, EMBO reports.

[29]  Daniel Öhlund,et al.  Fibroblast heterogeneity in the cancer wound , 2014, The Journal of experimental medicine.

[30]  M. Karsdal,et al.  Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer , 2014, Cancer medicine.

[31]  C. la Vecchia,et al.  Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  J. R. de los Toyos,et al.  Overexpression of COL11A1 by Cancer-Associated Fibroblasts: Clinical Relevance of a Stromal Marker in Pancreatic Cancer , 2013, PloS one.

[33]  M. Junttila,et al.  Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.

[34]  S. Ménard,et al.  Neoplastic and Stromal Cells Contribute to an Extracellular Matrix Gene Expression Profile Defining a Breast Cancer Subtype Likely to Progress , 2013, PloS one.

[35]  Mats Lambe,et al.  CD99 is a novel prognostic stromal marker in non‐small cell lung cancer , 2012, International journal of cancer.

[36]  Yuquan Wei,et al.  Chemical proteomics: terra incognita for novel drug target profiling , 2012, Chinese journal of cancer.

[37]  J. Shao,et al.  Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis , 2012, Journal of Translational Medicine.

[38]  C. Croce,et al.  MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer , 2011, Proceedings of the National Academy of Sciences.

[39]  B. Celli,et al.  Gender Differences in Plasma Biomarker Levels in a Cohort of COPD Patients: A Pilot Study , 2011, PloS one.

[40]  Rafael Sirera,et al.  The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[41]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[42]  R. Hynes.  The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.

[43]  R. Kalluri,et al.  Tumor stroma derived biomarkers in cancer , 2009, Cancer and Metastasis Reviews.

[44]  Chau-Chyun Sheu,et al.  Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. , 2006, Oncology reports.

[45]  W. Mcgregor,et al.  Gender difference in the activity but not expression of estrogen receptors α and β in human lung adenocarcinoma cells , 2006 .

[46]  E Helene Sage,et al.  Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. , 2003, Cancer research.

[47]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[48]  R. Simon,et al.  Flexible regression models with cubic splines. , 1989, Statistics in medicine.

[49]  L. Gasiorowski,et al.  In-vivo isolation of circulating tumor cells in non-small cell lung cancer patients by CellCollector. , 2017, Neoplasma.

[50]  W. Mcgregor,et al.  Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells. , 2006, Endocrine-related cancer.

[51]  Yang Zhang,et al.  Chinese a Nti鄄 Cancer a Ssociation , 2022 .